// App-Quantinova.ai

PO‐119 : Double heterozygocity for HbC and beta thalassaemia dominant: a rare cause of thalassaemia intermedia

Researchers

Presenter

  • A Agapidou

Principal Investigators

  • L Linpower

  • L Aiken

  • DA Tsitsikas

Medical Centers

  • Haemoglobinopathy Service, Department of Haematology, Homerton University Hospital NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • N/A

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • Hydroxycarbamide

  • Deferasirox

  • Ferriscan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved